Glenmede Trust’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$59.6K Buy
+12,268
New +$59.6K ﹤0.01% 1305
2021
Q2
Sell
-2,258
Closed -$209K 1280
2021
Q1
$209K Sell
2,258
-4,426
-66% -$410K ﹤0.01% 1057
2020
Q4
$598K Buy
6,684
+639
+11% +$57.2K ﹤0.01% 805
2020
Q3
$624K Sell
6,045
-722
-11% -$74.5K ﹤0.01% 723
2020
Q2
$535K Sell
6,767
-127
-2% -$10K ﹤0.01% 748
2020
Q1
$371K Hold
6,894
﹤0.01% 992
2019
Q4
$371K Sell
6,894
-508
-7% -$27.3K ﹤0.01% 992
2019
Q3
$386 Buy
7,402
+56
+0.8% +$3 ﹤0.01% 967
2019
Q2
$354 Sell
7,346
-606,923
-99% -$29.2K ﹤0.01% 998
2019
Q1
$31K Buy
614,269
+98,264
+19% +$4.96K 0.14% 226
2018
Q4
$30.6K Sell
516,005
-281,403
-35% -$16.7K 0.15% 205
2018
Q3
$52.5M Sell
797,408
-134,549
-14% -$8.86M 0.21% 135
2018
Q2
$47.1M Sell
931,957
-51,473
-5% -$2.6M 0.21% 150
2018
Q1
$45.7M Hold
983,430
0.19% 159
2017
Q4
$45.7M Sell
983,430
-528,961
-35% -$24.6M 0.19% 159
2017
Q3
$61.2M Sell
1,512,391
-212,989
-12% -$8.62M 0.27% 94
2017
Q2
$50M Hold
1,725,380
0.24% 116
2017
Q1
$50M Buy
1,725,380
+254,633
+17% +$7.38M 0.24% 116
2016
Q4
$48.3M Buy
1,470,747
+168,260
+13% +$5.53M 0.26% 103
2016
Q3
$41.1M Buy
1,302,487
+347,808
+36% +$11M 0.23% 118
2016
Q2
$26.8M Buy
954,679
+206,122
+28% +$5.8M 0.16% 219
2016
Q1
$27.2M Sell
748,557
-40,531
-5% -$1.47M 0.18% 195
2015
Q4
$31.6M Sell
789,088
-86,639
-10% -$3.47M 0.22% 134
2015
Q3
$24.9M Buy
875,727
+161,902
+23% +$4.61M 0.18% 175
2015
Q2
$23.5M Sell
713,825
-4,850
-0.7% -$160K 0.17% 204
2015
Q1
$20.7M Buy
718,675
+6,046
+0.8% +$174K 0.15% 223
2014
Q4
$19.4M Buy
712,629
+48,034
+7% +$1.31M 0.15% 216
2014
Q3
$14.2M Buy
664,595
+84,023
+14% +$1.79M 0.12% 245
2014
Q2
$13M Buy
580,572
+165,649
+40% +$3.72M 0.12% 254
2014
Q1
$10.5M Buy
+414,923
New +$10.5M 0.1% 281